Aziyo Biologics Inc reports results for the quarter ended in March - Earnings Summary

Elutia

10/05/2022 09:06

* Aziyo Biologics Inc  AZYO.OQ  reported a quarterly
adjusted loss
of 60 cents​​ per share for the quarter ended in March. The mean
expectation of three analysts for the quarter was for a loss
of 62 cents per share.
    * Revenue fell 10.8% to $11.50 million from a year ago; 
analysts
expected $10.78 million. 
    * Aziyo Biologics Inc's reported EPS for the quarter was a
loss
of 60 cents​.
    * The mean earnings estimate of analysts had fallen by
about 7.5%
in the last three months.​ 
    * In the last 30 days there have been no negative revisions
of
earnings estimates 
    * Aziyo Biologics Inc shares had risen by 7.9% this
quarter and
gained 1.9% so far this year.
    * The company reported a quarterly loss of $8.15 million.
    * Wall Street's median 12-month price target for Aziyo
Biologics
Inc is $11.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated May 10 at 08:06 a.m.  ​All
figures in US dollars unless otherwise stated